Agenda. Principle of Operation Key Features Key Applications in Toxicology Examples of Toxicology Applications Technical Documentation

Similar documents
isobaric Barbiturates in Serum using LDTD- MS/MS combined with differential mobility

Abstract. Experimental Sample Preparation

Ion Source. LUXON ION SOURCE The fastest process for mass spectrometry

LC-MS/MS Analysis of Phytocannabinoids and their

Ion Source. LUXON ION SOURCE The fastest process for mass spectrometry

Ion Source. LUXON ION SOURCE The fastest process for mass spectrometry

Analysis of Cannabinoids and Amphetamines in Serum by RRLC/Triple Quadrupole Mass Spectrometry Using a Multimode Ion Source. Application.

Psychoactive Drugs Urine LC-MS/MS Analysis Kit User Manual

Ultrafast Analysis of Methadone and Metabolite EDDP in Urine by the Agilent RapidFire High-Throughput Mass Spectrometry System

Opiates in Urine by SAMHSA GC/MS

Benzoylecgonine in Urine by SAMHSA GC/MS

DRD Trends in Portugal: Updates From Forensic Toxicology Services

Rapid Screening and Confirmation of Melamine Residues in Milk and Its Products by Liquid Chromatography Tandem Mass Spectrometry

Maximizing Triple Quadrupole Mass Spectrometry Productivity with the Agilent StreamSelect LC/MS System

LC-MS/MS Method for the Determination of Diclofenac in Human Plasma

The Use of the ACQUITY QDa Detector for a Selective, Sensitive, and Robust Quantitative Method for a Potential Genotoxic Impurity

The role of LC-MS in Toxicology

Improved Extraction of THC and its Metabolites from Oral Fluid Using Oasis PRiME HLB Solid Phase Extraction (SPE) and a UPLC CORTECS C 18

Mass Spectrometry. Hyphenated Techniques GC-MS LC-MS and MS-MS

Solid Phase Micro Extraction (SPME) of Opiates from Urine: Coupling SPME and DESI-MS/MS Detection

Amphetamines, Phentermine, and Designer Stimulant Quantitation Using an Agilent 6430 LC/MS/MS

Analysis of Synthetic Cannabinoids and Metabolites: Adding New Compounds to an Existing LC-MS/MS Method

Ultrafast Analysis of Buprenorphine and Norbuprenorphine in Urine Using the Agilent RapidFire High-Throughput Mass Spectrometry System

AB SCIEX SelexION Technology Used to Improve Mass Spectral Library Searching Scores by Removal of Isobaric Interferences

Overview. Introduction. André Schreiber AB SCIEX Concord, Ontario (Canada)

Fast and Reliable Method for the Analysis of Methylmalonic Acid from Human Plasma

1.11 Measurement Uncertainty

Forensic and toxicological drug screening using liquid chromatography-tandem mass spectrometry with MS/MS library based identification

A Rapid Approach to the Confirmation of Drug Metabolites in Preclinical and Clinical Bioanalysis Studies

VMA, HVA, 5-HIAA Urine LC-MS/MS Analysis Kit User Manual

Direct Analysis of Opioids and Metabolites from Whole Blood Using Ostro Sample Preparation Plates Combined with UPLC-MS/MS for Forensic Toxicology

[application note] INTRODUCTION EXPERIMENTAL. Specimens. Extraction

Yun W. Alelyunas, Mark D. Wrona, Russell J. Mortishire-Smith, Nick Tomczyk, and Paul D. Rainville Waters Corporation, Milford, MA, USA INTRODUCTION

Prepared By: R. W. Waggoner, Jr. Effective Date: August 18, 2008

Determination of Cannabinoids (THC) in Biological Samples

Quantitative Analysis of EtG and EtS in Urine Using FASt ETG and LC-MS/MS

Quantitative Analysis of EtG and EtS in Urine Using FASt ETG and LC-MS/MS

Quantitative analysis of mitragynine in human urine by high performance liquid chromatography-tandem mass spectrometry

Authors. Introduction. Abstract. Forensics

Agilent TOF Screening & Impurity Profiling Julie Cichelli, PhD LC/MS Small Molecule Workshop Dec 6, 2012

TANDEM MASS SPECTROSCOPY

LC-MS/MS in the Clinical Laboratory. Jo Adaway

High-Throughput LC-MS/MS Quantification of Estrone (E1) and Estradiol (E2) in Human Blood Plasma/Serum for Clinical Research Purposes

General. Power requirements: 110/220 Volts 50/60 VAC. Dimensions: Width 80 cm x Height 45 cm x Depth 58 cm. Weight: 57 Kg.

Analysis of Serum 17-Hydroxyprogesterone, Androstenedione, and Cortisol by UPLC-MS/MS for Clinical Research

Introduction to Pharmaceutical Chemical Analysis

METHADONE and EDDP in urine by GC-MS Code GC Method of Confirmation by GC-MS

Quantitative analysis of small molecules in biological samples. Jeevan Prasain, Ph.D. Department of Pharmacology & Toxicology, UAB.

LC-MS Based Metabolomics

Rapid, Robust, and Sensitive Detection of 11-nor-D 9 - Tetrahydrocannabinol-9-Carboxylic Acid in Hair

Technical Procedure for Blood Cannabinoid Liquid-Liquid Extraction (BCLLE) for Analysis by LC-MS/MS

Plasma Metanephrines and 3-Methoxytyramine by LC/MS/MS Using Agilent SimpliQ WCX SPE, 1290 Infi nity LC, and 6460 Triple Quadrupole LC/MS

LC/MS/MS qua ntitation of β-estradiol 17-acetate using an Agilent 6460 Triple Quadrupole LC/MS working in ESI negative ion mode

New Dynamic MRM Mode Improves Data Quality and Triple Quad Quantification in Complex Analyses

Contact Information. Speaker Financial Disclosure Information. Fitting Linear Quadrupoles and Round Flight Tubes into the Square Clinical Laboratory

Analyte Targeting for NPS Identification in Seized Drugs and Toxicology

TargetScreener. Innovation with Integrity. A Comprehensive Screening Solution for Forensic Toxicology UHR-TOF MS

LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY (LC/MS) Presented by: Dr. T. Nageswara Rao M.Pharm PhD KTPC

Journal of Analytical Toxicology Advance Access published April 24, 2012

Analysis of Illegal Dyes in Food Matrices using Automated Online Sample Preparation with LC/MS

Complementary Role of GC/MS in Clinical Laboratory and Beyond

Macrolides in Honey Using Agilent Bond Elut Plexa SPE, Poroshell 120, and LC/MS/MS

Confirmation and Quantitation of THC in Oral Fluid Using an MRM Method on a GC-Triple Quadrupole MS

Improved Automated Sample Preparation for the Analysis of 25-OH-Vitamin D3 by LC/MS/MS

Making Sense of Differences in LCMS Data: Integrated Tools

Proudly serving laboratories worldwide since 1979 CALL for Refurbished & Certified Lab Equipment

Bioanalytical Chem: 4590: LC-MSMS of analgesics LC-MS Experiment Liquid Chromatography Mass Spectrometry (LC/MS)

Semi-quantitative Determination of Concentrations in Systematic Toxicological Analysis by LC-QTOF-MS

Determination of Pharmaceuticals in Water by SPE and LC/MS/MS in Both Positive and Negative Ion Modes Application

Hplc Lc Ms And Gc Method Development And Validation Guideline For Academic And Industrial Scientists Involved In Method Development And Validation

Simultaneous analysis for forensic drugs in human blood and urine using ultra-high speed LC-MS/MS

Plasma-free Metanephrines Quantitation with Automated Online Sample Preparation and a Liquid Chromatography-Tandem Mass Spectrometry Method

Analysis of Pharmaceuticals and Personal Care Products in River Water Samples by UHPLC-TOF

SAMHSA-Compliant LC/MS/MS Analysis of Phencyclidine in Urine with Agilent Bond Elut Plexa PCX and Agilent Poroshell 120

Rapid, Reliable Metabolite Ratio Evaluation for MIST Assessments in Drug Discovery and Preclinical Studies

Exploring the Benefits of Automated Unattended Sample Derivatization Prior to Gas Chromatography Analysis

HPLC Winter Webinars Part 2: Sample Preparation for HPLC

Hplc Lc Ms And Gc Method Development And Validation Guideline For Academic And Industrial Scientists Involved In Method Development And Validation

Analysis of Opioids Using Isotope Dilution with GCMS-TQ8030 GC/MS/MS. No. GCMS No. SSI-GCMS-1401

High-Throughput Confirmation and Quantitation of a THC Metabolite in Urine Using the DSQ II GC/MS

Application Note. Gas Chromatography/Mass Spectrometry/Food Safety. Abstract. Authors

Definitive EtG/EtS LC-MS/MS Analysis:

Benzodiazepines and Barbiturates

HANDBOOK OF DRUG ANALYSIS

Uncontrolled Copy. SOP 109 Ethylene Glycol Screen by Gas Chromatography/Mass Spectrometry. Table of Contents. 1. Principle of Assay...

Toxicology Extraction Procedure for Base Drugs Using United Chemical Technologies Clean Screen Extraction Columns

Introduction to LC-MS

1. The range of frequencies that a measurement is sensitive to is called the frequency

Catecholamines Urine LC-MS/MS Analysis Kit User Manual

Analysis of Drugs in Hair using GC/GC/MS CAT Meeting 3/2/07

Agilent G3212 GC-APCI Source

Analysis of Polar Metabolites using Mass Spectrometry

Evaluation of a New HPLC, a New Tandem MS and a New Data Processing Software for General Clinical Use

A High Sensitivity Dual Solid Phase Extraction LC-MS/MS Assay for the Determination of the Therapeutic Peptide Desmopressin in Human Plasma

Strategies for the Analysis of Therapeutic Peptides in Biofluids by LC-MS/MS. Lee Goodwin

Extraction of Cocaine and Metabolites From Urine Using ISOLUTE SLE+ prior to LC-MS/MS Analysis

Rapid and Accurate Forensics Analysis using High Resolution All Ions MS/MS

Drug-Control Laws. CRIMINALISTICS An Introduction to Forensic Science, 9/E. PRENTICE HALL 2007 Pearson Education, Inc.

SECOBARBITAL Latest Revision: February 15, 1999

NORBUPRENORPHINE (Buprenorphine s Metabolite ) BUPRENORPHINE in urine by GC/MS Code GC Method of Confirmation by GC-MS

Transcription:

Agenda Principle of Operation Key Features Key Applications in Toxicology Examples of Toxicology Applications Technical Documentation

LDTD: Laser Diode Thermal Desorption High-Throughput Ion source Plug-and-play front end solution 4-6 seconds sample-to-sample analysis time Can be combined with AB Sciex Ion Mobility Source (SeleXion ) for separation of Isobaric compounds Sensitivity, accuracy, linearity and reproducibility equivalent or superior to LC-ESI and APCI Used for Small molecule analysis (< 1200 amu)

Principle of operation What is Laser Diode Thermal Desorption? Plate IR Laser Beam Metal Sheet Sample dried into the well cavity No photon interactions with the sample Continuous laser (no pulse) Ultra fast heating transfer Quantitative sample desorption

Principle of operation Ion Transfer Process: LazWell Sample Plate with metal insert Carrier Gas IR Laser Beam Transfer Tube Mass Spectrometer Inlet Piston head Piston Corona Discharge Needle

Principle of operation Ionization Process for LDTD : The Atmospheric Pressure Chemical Ionization (APCI) of the LDTD is exempt of solvent and mobile phase: Reinvented APCI Water molecules are the sole source of protons (H + ) Low temperature process, 30⁰ Celsius Carrier Gas H 2 O O 2 N 2 Corona Discharge H 2 O H 2 O + H 3 O + N + 2 N 2 e - e - + + + + + + + + High Voltage H 2 O N 2 + N + 2 e - N 2 N + e - 4 (H 2 O) n H + + Analyte Analyte is forced to react with the cluster ion producing a complete ionization

Market Differentiation There are two ways to improve the speed of analysis on a LC-MS/MS system Work with the LC Multiplexing TLX/LX (Thermo) UPLC (Waters, Shimadzu, etc) Shotgun approach No chromatography LDTD-Phytronix Biocius RapidFire (Agilent)

Key Features The thermal desorption process takes seconds Low volume sample analysis (1 to 10 µl) 96-well plates are designed to be compatible with conventional sample preparation systems Elimination of carry over due to LC (needle wash) Each well is individually isolated during the thermal desorption Plug-and-play device with all Mass Spec OEM Low maintenance system Small molecule analysis only

Key Features Plug-and-play device Full software compatible with MassLynx, Xcalibur, Analyst Thermo AB Sciex No need to modify the actual MS 96-Well and 384-Well LDTD Devices available Agilent Waters

Applications TOXICOLOGY CRO FOOD PHARMACEUTICAL ENVIRONMENT CLINICAL

Various Applications: Toxicology and Forensics (Drugs of abuse screening): Urine screening Urine confirmation Opiates (SeleXion) Environmental, Personal Health Care products in water Emerging contaminants in waste water Cyanotoxin Food analysis, antibiotic detection and quantification Antibiotics in milk, honey, shrimp, etc. Melamine testing Clinical analysis Testosterone in plasma (Combined with AB Sciex - SeleXion ) Vitamin D

Drug Confirmation on LDTD-MS Gold standard related to drug class GC-MS (Trap) and LC-MS/MS Time-consuming system : run can take up to 30 minutes GC-MS often requires a chemical derivatization LDTD-MS/MS MS/MS allows high specificity Sensitivity down to low ng/ml Runtime : 10 seconds per sample Allows multi-analyte confirmation including metabolite(s)

Drug Confirmation on LDTD-MS LDTD-Q-TOF Exact mass measurement (qualitative information) Possible retro-action on the results Very fast system : 10 sec / sample Large number of drugs can be targeted LDTD-Triple-TOF Accurate mass measurement meets MS/MS specificity Comparable sensitivity to a triple-quad system (down to low ng/ml) Runtime : 10 seconds per sample Allows multi-analyte confirmation including analytes and metabolites

Drug Coverage on LDTD Analgesics and Opiates such as Natural: Morphine, Codeine, Oxymorphone, Oxycodone, Hydrocodone Synthetics: Tramadol, Demerol, Fentanyl, Methadone, Darvon, Heroin Cannabinoids Natural: THCA Synthetics: K2/SPICE (JWH-018 + JWH-073) both OH and COOH metabolites Benzodiazepines and Barbiturates Street drugs such as Amphetamines, Cocaine, Ecstasy (MDA, MDMA,MDEA)

Toxicology Application High-Throughput Screening of Synthetic Cannabinoids using LDTD-TripleTOF

LDTD-TripleTOF 5600 System Synthetic cannabinoids have similar biologic activities as natural cannabis, THC. 5 compounds are already considered illegal in the United States (Controlled Substances Act March 1, 2011 Federal Register) Drugs are constantly changing in structure to bypass state legislation. We are therefore dealing with a moving target. To properly identify and quantify these drugs, we need : A fast, selective, and sensitive quantitative method: LDTD- HR-TOF MS/MS A system that allows for a fast screening of samples: LDTD-HR-TOF A way to select and target the best ions to extract MS/MS spectra during a sample screening run (Information Dependant Acquisition)

High Resolution Quantitation 5-hydroxylpentyl-JWH-018 4-hydroxylbutyl-JWH-073 5-carboxylbutyl-JWH-018 4-carboxylbutyl-JWH-073 Range of drug concentrations in urine: 0.2 to 1000 ng/ml Sample Preparation: 100µL Urine 100µL Methanol/HCl (0.5N) [1:1v/v] with IS (Clomiphene) 300µL 1-Chlorobutane Vortex and Centrifuge 200µL from organic phase is evaporated Reconstitute with 20µL of Methanol/Water [75:25 v/v] 2µL used for LDTD analysis with a runtime of 8 seconds/sample

High Resolution Quantitation Drug Nominal Mass (amu) High Resolution Fragment (amu) 4-hydroxybutyl-JWH-073 344.3 155.0410 155.0510 5-hydroxypentyl-JWH-018 358.3 230.1104 230.1154 4-carboxylbutyl-JWH-073 358.3 230.0740 230.0790 Specific Fragments 5-carboxylpentyl-JWH-018 372.3 155.0410 155.0510 High Resolution permits the quantitation of 2 molecules that have the same Nominal Mass and structure. Dynamic range in the 3.5 order of magnitude

High Resolution Quantitation Drug LOD (ng/ml) LOQ (ng/ml) 4-hydroxybutyl-JWH-073 0.22 0.73 5-hydroxypentyl-JWH-018 0.01 0.04 4-carboxylbutyl-JWH-073 0.36 1.2 5-carboxylpentyl-JWH-018 0.36 1.2

Conclusion The specific sample preparation method provided allows for a high quantitation range of 2 to 4000 ng/ml of JWH compounds on LDTD-TOF. This analysis mode can simultaneously detect multiple drugs. It is possible to perform a screening and quantification during the same analysis. To expand the range of compounds able to be detected in a sample, it may be preferable to use a generic extraction method. Immunoassay Fast System (10-30 seconds / sample) Expensive reagents Limited number of reagents available More or less accurate response (crossreactivity) LDTD-TripleTOF 5600 Fast System (5 seconds / sample) Unlimited number of compounds for detection Possible feedback actions during analysis

Generic Multi-Drug HR Quantitation Generic Sample Preparation Liquid-liquid (Acid) Extraction 50 µl Urine 50 µl HCl 0.2 N with 50ng/mL Clomiphene (IS) 200 µl 1-chlorobutane 2 µl of organic phase analyzed on LDTD-TripleTOF 5600 Liquid-Liquid (Basic) Extraction 50 µl Urine 50 µl NaOH 0.2 N with 50ng/mL Clomiphene (IS) 200 µl Ethyl Acetate 2 µl of organic phase analyzed on LDTD-TripleTOF 5600 Urine Samples spiked with: Fentanyl/Norfentanyl, Propoxyphene/Norpropoxyphene, Methadone/EDDP, Codeine, Morphine, Oxycodone, Oxymorphone, Diazepam, Estazolam, Hydroalprazolam, Hydroethylflurazepam, Hydromidazolam, Hydroxytriazolam, Lorazepam, Nordiazepam, Oxazepam, Temazepam, 7-aminoclonazepam, 7-aminoflunitrazepam, Chlorodiazepoxide, Meperidine/Normeperidine, 5-hydroxypentyl-JWH-018 and 4-hydroxybutyl-JWH-073 Concentrations vary between 25 et 600 ng/ml, depending on the typical immunoassay cutoff range for each of the drugs. There are currently no Immunoassays available for the detection of synthetic cannabinoids.

Generic Multi-Drug HR Quantitation Estazolam Methadone Oxycodone Chlordiazepoxide Temazepam 5 Second Runtime Codeine Oxymorphone Lorazepam Example of a mass spectrum analysis from a basic extraction

Toxicology Analysis Methadone and EDDP confirmation in urine samples

Methadone and EDDP Sample Preparation Labelled internal standard used Solid Phase Extraction using a basic elution 2µL of extract were used on LDTD-MS/MS Run-time : 8 seconds / sample Calibration Curves 15 to 9600 ng/ml (r 2 >0.998) Accuracy (back-calculation) from 84 to 117 % Methadone EDDP

Methadone and EDDP Intra-run (n=24) on 1 specimen sample Methadone EDDP Target Concentration (ng/ml) 2132 2956 Average Concentration (ng/ml) 2247 2735 SD (ng/ml) 66 130 CV (%) 3.0 5.0 Inter-run: Over 40 specimens run in 3 different batches; CV s between 0.7 and 19.1 % (EDDP being more variable) * LDTD has withstood Joint Commission (JCAHO) and CAP audits.

Method Accuracy Results 40 specimens run in LDTD-MS/MS and in GC-MS (reference lab) No bias between both methods (within ± 20 %) 2 samples from the College of American Pathologists (CAP) were run and gave results within 1SD of the CAP survey results Sample stability, Carry-over and Interferences LazWell plate stability : within 3-days Carry-over not observed No interferences observed (Phenylpanolamine, Pseudo-ephedrine, Ibuprofen, Lidocaine, Procaine, Ephedrine, Caffeine and Acetaminophen)

Clinical Application Selectivity Enhancement in High Throughput Analysis of Testosterone using Differential Ion Mobility to LDTD-MS/MS MASCL 2012

Testosterone

Sample Preparation for Analysis Gain in Specificity with DMS allows a simple preparation: Spike standard curve in stripped plasma Liquid-liquid extraction with MTBE 1:4 v/v ratio Vortex 10 seconds 2 µl of the upper layer directly spotted onto the Lazwell plate Dry at room temperature MS/MS

Effect of Ion Mobility

SeleXionTM

Results High sensitivity with LOQ at 0.1 ng/ml (50 femtogram on plate) Excellent linearity, with r 2 = 0.99972, over 5 orders of magnitude Accuracy and reproducibility were within the accepted values as shown in the table below. The sample-to-sample run time was only 7 seconds. In comparison, the equivalent analysis using conventional LC-MS/MS would typically require approximately 3-5 minutes per sample

More Publications

Conclusions Thermal desorption in induced indirectly by laser diode No photon-sample interactions There is no need for an enhancement matrix There is no liquid mobile phase Ionization is produced by corona discharge Sample-to-sample run time as low as 5 seconds

Conclusions Picogram sensitivity can be achieved using 2-5 μl of sample Added benefits using AB Sciex SeleXion source for Isobaric compounds No carryover or memory effect Comparable performance to LC-MS/MS with higher throughput

Comparison Procedure GC/MS LC/MS/MS LDTD/MS/MS Applicability to target screening Medium High High Effort on sample preparation High Low/Medium Low/Medium Risk of biological matrix effect Low High Medium Risk of carry-over High High (extensive needle wash) Very Low Analysis specificity Low/Medium High High Sensitivity Medium High High Thermolabile compounds analysis Low to medium Medium/High Medium/High Quantification power Medium/High High High System maintenance Medium High Very Low Analytical speed Low Medium (Higher UPLC) Very High

Technical Documentation Please visit www.phytronix.com for application notes, poster and presentations. Complete References of scientific papers are available on the web site. Specific applications and presentations available on demand to the marketing team. For more information, please contact: Global Sales and Marketing Alex Birsan, Research Scientist a.birsan@phytronix.com @Phytronix

Questions

LDTD and Mass Spectrometry The LDTD-APCI ion source can be adapted to : Triple quadrupole MS Ion trap MS Q-TOF systems Triple-TOF system (AB Sciex 5600) The LDTD allows : Fast qualitative screening Fast quantitative screening Fast confirmation results

Generic Multi-Drug HR Quantitation Screening Example Fixed limit of detection : 10 ng/ml Blank No. 1 No. 2 No. 3 No. 4 No. 5 No. 6 No. 7 No. 8 No. 9 No. 10 Real Patient sample (unknown concentrations) evaluated for JWH-018 (OH- Metabolite) M.W. 357.4 g/mol - HR-TOF : 358.18016 amu

Generic Multi-Drug HR Quantitation Screening Example Fixed limit of detection : 10 ng/ml Blank No. 1 No. 2 No. 3 No. 4 No. 5 No. 6 No. 7 No. 8 No. 9 No. 10 Real Patient sample (unknown concentrations) evaluated for JWH-250 (OH- Metabolite) M.W. 351.2 g/mol - HR-TOF : 352.19072 amu

Toxicology Analysis Propoxyphene and Norpropoxyphene confirmation in urine samples

Sample Preparation Propoxyphene / Norpropoxyphene Labelled internal standard used Solid Phase Extraction using a basic elution 2 µl of extract were used to run LDTD-MS/MS analysis Run-time : 14 seconds / sample Calibration Curves 25 to 12800 ng/ml (r 2 >0.99) Accuracy (back-calculation) from 90.9 to 114 % Propoxyphene Norpropoxyphene

Propoxyphene / Norpropoxyphene Intra-run (n=15) for 3 specimens Sample 1 Sample 2 Sample 3 Average Concentration (ng/ml) PPX NPPX 182.9 1729.2 SD (ng/ml) 11.9 33.7 CV (%) 6.5 1.9 Average Concentration (ng/ml) 459.9 12.600 SD (ng/ml) 12.8 233.5 CV (%) 2.8 1.9 Average Concentration (ng/ml) 3395.8 21,733.3 SD (ng/ml) 71 465.8 CV (%) 2.1 2.1 Inter-run: Over 40 specimens run in 3 different batches; CV s below 6.3 %

Method Accuracy Propoxyphene / Norpropoxyphene 40 specimens run in LDTD-MS/MS and in GC-MS (reference lab) LDTD-MS/MS calibration range 25-12800 ng/ml GC-MS calibration range 50-4000 ng/ml No bias between both methods (within ± 20 %) Sample stability, Carry-over and Interferences LazWell plate stability : within 3-days Carry-over not observed No interferences observed (Phenylpanolamine, Pseudo-ephedrine, Ibuprofen, Lidocaine, Procaine, Ephedrine, Caffeine and Acetaminophen)

Is it like MALDI? Differences between LDTD and MALDI Wide Infrared Laser Beam at 3 mm diameter LDTD Carrier Gas Laser beam MALDI Metal Sheet Neutral Ion High Efficiency APCI Ionization NO interaction photon-molecule Dry sample in the bottom of the well Thermal Vaporisation by fast and precise heat transfert Complete Vaporisation of the sample Matrix needed for ionizaiton Pulsed Laser reacting with the sample Important matrix effects and adducts Sampling of the surface

Market Differentiation Differences between LDTD and RapidFire Dried sample thermally desorbed every 5 seconds Highly resistant to Ionic suppression and matrix effect APCI based ionization No CarryOver Plug and Play device, easy to use Generic method for most of compounds Much cleaner, less MS inlet maintenance and shut down Liquid sample by switching valve every 5 seconds No separation High ionic suppression and matrix effect High Carry Over ESI based ionization SPE online sample preparation multiple cartridges tuning method necessary Complex, Expensive maintenance cost

Relative Abundance Relative Abundance High-Throughput LDTD-MS/MS analysis RT: 0.08-1.00 SM: 13G 100 90 80 70 60 50 NL: 1.40E5 TIC F: + c ESI SRM ms2 152.000@cid16.00 [110.095-110.105] MS ICIS Batch12B3 RT: 0.00-7.74 100 90 80 70 SM: 7G 96-Replicates NL: 2.18E5 TIC F: + c ESI SRM ms2 152.000@cid16.00 [110.095-110.105] MS Plaquette5_08042210 3040 40 30 60 20 50 10 40 100 0 90 80 NL: 1.38E5 TIC F: + c ESI SRM ms2 156.000@cid16.00 [113.995-114.005] MS ICIS Batch12B3 30 20 70 10 60 50 40 30 20 10 100 0 90 80 70 NL: 1.79E5 TIC F: + c ESI SRM ms2 156.000@cid16.00 [113.995-114.005] MS Plaquette5_08042210 3040 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 Time (min) 60 50 40 Analyte Desorption in 1.8 seconds 30 20 10 0 0 1 2 3 4 5 6 7 Time (min)